RCT | Efficacy of different treatment regimens in unresectable colorectal cancer liver metastases

First-line systemic treatment strategies in patients with initially unresectable colorectal cancer liver metastases (CAIRO5): an open-label, multicentre, randomised, controlled, phase 3 study from the Dutch Colorectal Cancer Group – The Lancet Oncology (link to abstract – $ for full-text)

Commentary on Twitter

ICYMI: The CAIRO5 open-label, multicentre, randomised, phase 3 trial of first-line systemic treatment strategies in patients with initially unresectable colorectal cancer liver metastases. #ccsmhttps://t.co/PiiwFcktLn pic.twitter.com/wlQbmuDLOW

— The Lancet Oncology (@TheLancetOncol) July 5, 2023